Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM. — المؤلف: Huemer, Florian — European journal of haematology 20191114
- المؤلف
- Huemer, Florian
- النشر
- European journal of haematology 20191114
- الوصف
- 437-441 p.
- الموضوعات
- Aged؛ Aged, 80 and over؛ Antineoplastic Agents؛ Bcl-2-Like Protein 11؛ Biomarkers, Tumor؛ Bridged Bicyclo Compounds, Heterocyclic؛ DNA Methylation؛ Drug Resistance, Neoplasm